The institution’s latest advancements in radiation treatment of cancer will be showcased in 10 presentations, including four oral presentations NEW BRUNSWICK, N.J., Sept. 29, 2023 /PRNewswire/ — Physician-scientists from Rutgers Cancer Institute of New Jersey […]
The gene therapy startup Lexeo Therapeutics filed paperwork to go public Friday afternoon, as the pre-Thanksgiving IPO window shrinks and a government shutdown looms. The New York-based biotech would join about a dozen other drug developers […]
NEWTOWN, Pa., Sept. 29, 2023 /PRNewswire/ — Company Contact: Name: Susan DiCroce Phone Number: (215) 579-1842 Ext: 1260 KVK-Tech, Inc. is voluntarily recalling one lot (Batch Number: 17853A; “the batch”) of Betaxolol Tablets, USP 10 […]
The Innovation Space’s portfolio of 115 companies have now raised over $1 billion. Click here to view original post
In other Philadelphia-area life sciences news, the FDA awarded Aro Biotherapeutics a rare pediatric drug designation for its experimental treatment also for Pompe disease. Click here to view original post
A number of jobs were eliminated from a behavioral health unit at a Montgomery County hospital, but a nurses union and the health system are at odds over how many positions were impacted. Click here […]
Builds upon a previous $15.6 million grant that boosted efforts in 2019. Click here to view original post
The deadline for drugmakers to sign agreements to negotiate with Medicare on pricing is this Sunday. Click here to view original post
Altesa BioSciences has raised a $35 million Series A from undisclosed investors, according to an SEC filing from July. The company develops antiviral drugs for chronic obstructive pulmonary disease from viruses that cause the common […]
The Nasdaq is welcoming another company hustling along a late-stage drug, with Adlai Nortye raising $97.5 million from an IPO and a concurrent private placement. Adlai Nortye licensed its lead program, the PI3K inhibitor buparlisib, […]
Copyright © 2023 Biotech Networks, LLC
